NAVCO Pharmaceuticals Inc. (TSXV:NAV)
Canada · Delayed Price · Currency is CAD 0.0050
0.00 (0.00%)
At close: Jan 14, 2026
NAVCO Pharmaceuticals Company Description
NAVCO Pharmaceuticals Inc. develops and commercializes supplemental and therapeutic consumer health and wellness products in the areas of antibacterial and immunity support and infectious disease prevention in Canada.
The company offers aerosol sprays, hand cleansers, hand creams, and nano bioguard; and disinfectant spray products.
It also provides diagnostic testing, textile, PPE, and food solutions. Its products are used in medicine, textiles, chemicals, and additives industries to combat microorganisms, such as viruses and bacteria.
NAVCO Pharmaceuticals Inc. is headquartered in Burlington, Canada.
NAVCO Pharmaceuticals Inc.
| Country | Canada |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Geoffrey Lee |
Contact Details
Address: 5205 Harvester Road Burlington, ON L7L 6B5 Canada | |
| Phone | 289 430 5190 |
| Website | navcopharma.com |
Stock Details
| Ticker Symbol | NAV |
| Exchange | TSX Venture Exchange |
| Fiscal Year | October - September |
| Reporting Currency | CAD |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Geoffrey Lee | Chief Executive Officer |
| Christopher R. Cooper | Chief Financial Officer |
| Marek Jasinski | Chief Operating Officer and Director |
| Thomas Jusdanis | Corporate Secretary and Independent Director |